BRISTOL-MYERS SQUIBB COMPANY Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) of $3.00 billion for the 12-month period ending 2012-12-31, per its 10-Q filed 2013-04-25.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount · last filed 2014-02-14
- BRISTOL-MYERS SQUIBB COMPANY stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2012-06-30 was $0.00.
- BRISTOL-MYERS SQUIBB COMPANY stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2012-03-31 was $3.00B.
- BRISTOL-MYERS SQUIBB COMPANY stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2011-12-31 was $0.00.
- BRISTOL-MYERS SQUIBB COMPANY stock repurchase program, authorized amount (deprecated 2014-01-31) for fiscal 2011 was $3.00B, a 0.00% change from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY stock repurchase program, authorized amount (deprecated 2014-01-31) for fiscal 2010 was $3.00B.
| Period end | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|---|
| 2012-12-31 | $3.00B 10-Q · filed 2013-04-25 | ||||
| 2012-06-30 | $3.00B 10-K · filed 2014-02-14 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $3.00B 10-Q · filed 2012-07-25 | $3.00B derived: sum of 3 quarters · filed 2012-07-25 | |
| 2012-03-31 | $3.00B 10-Q · filed 2012-04-26 | $3.00B derived: sum of 2 quarters · filed 2012-04-26 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $3.00B 10-K · filed 2012-02-17 | |||
| 2011-09-30 | $3.00B 10-Q · filed 2011-10-27 | ||||
| 2010-12-31 | $3.00B 10-K · filed 2013-02-15 | ||||
| 2010-06-30 | $3.00B 10-Q · filed 2011-07-28 | ||||
| 2010-05-31 | $3.00B 10-Q · filed 2013-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |